Gilead Sciences (GILD) reported 6.95billioninrevenueforthequarterendedJune2024,representingayear−over−yearincreaseof5.42.01 for the same period compares to 1.34ayearago.Thereportedrevenuerepresentsasurpriseof+4.716.64 billion. With the consensus EPS estimate being $1.61, the EPS surprise was +24.84%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...